Clinical Trials Directory

Trials / Unknown

UnknownNCT03405324

Effect of tDCS of the Motor Cortex on Chemotherapy Induced Nausia and Vomiting

Effect of the Transcranial Direct Current Stimulation (tDCS) of the Motor Cortex on Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Shereen Mamdouh · Academic / Other
Sex
Female
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

this work is looking for the effect of tDCS of the motor cortex on the chemotherapy induced nausea and vomiting in cancer breast patients

Detailed description

Chemotherapy has played an important role in improving patient outcomes in oncology and is a cornerstone of therapy for most patients with cancer. Of the adverse effects, none is more feared than chemotherapy-induced nausea and vomiting (CINV). Nausea and vomiting can adversely affect patients' quality of life and make it difficult for them to perform their activities of daily living. Uncontrolled CINV can give rise to medical complications, including poor nutrition, dehydration, electrolyte imbalances, and physical and mental deterioration.The introduction and development of antiemetic drugs have significantly improved the ability of clinicians to control CINV. The mainstays of antiemetic therapy include serotonin (5-HT3) receptor antagonists (RAs) and neurokinin 1 (NK-1) RAs. Researchers and patients are seeking additional methods of controlling CINV, such as non-drug therapies. Transcranial direct current stimulation (tDCS) is a relatively simple technique requiring only a few parts.

Conditions

Interventions

TypeNameDescription
DEVICEtDCSa single session of tDCS over the primary motor cortex with constant current of 2mA intensity will be applied for 20 minutes with a 5-second ramp phase at the beginning.
DEVICEsham tDCSsham tDCS

Timeline

Start date
2018-01-01
Primary completion
2019-02-01
Completion
2019-09-01
First posted
2018-01-23
Last updated
2019-06-28

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03405324. Inclusion in this directory is not an endorsement.